Amitabh Dube, Country President and Managing Director, Novartis India shares his reactions on Union Budget 2023-24
"We welcome the Union Budget 2023-24 announced by FM Nirmala Sitharaman and applaud the focus on research and innovation as these factors are essential in driving value-added growth. Fostering a robust research ecosystem will help in achieving universal health coverage by enabling accessibility, and availability of life-saving medicines. It will also improve India's intellectual capital and contribute to accelerating our growth toward becoming a $10 trillion economy by 2035.
As an organisation, we have a long-standing commitment and have undertaken several initiatives to improve the lives of those affected by sickle cell disease (SCD) and the announcement by FM to eliminate sickle cell anaemia by 2047 is very encouraging. We look forward to establishing more significant partnerships with relevant government stakeholders towards providing a comprehensive SCD management ecosystem to the patients.”